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Abstract 
Areca nut, commonly called as betel nut or supari, is a fruit of areca catechu palm tree, which is native of South 
Asia and Pacific Islands. The seed or endosperm is consumed fresh, boiled or after sun drying or curing. Chewing 
areca nut is thought to have central nervous system stimulating effect and along with this it is known to have sali-
vary stimulating and digestive properties. According to the traditional Ayurvedic medicine, chewing areca nut and 
betel leaf is a good remedy against halitosis. It is also used for its deworming property. Along with these beneficial 
effects of areca nut one of its most harmful effects on the human body in general and oral cavity in particular is the 
development of potentially malignant disorder called Oral Submucous Fibrosis.
The present paper discusses in detail the effects of the components of areca nut on pathogenesis of Oral Submucous 
Fibrosis.
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Introduction
Areca nut or supariis a fruit of areca catechu palm tree, 
which is native of South Asia and Pacific Islands. It is com-
monly called as betel nut as it is often chewed wrapped in 
betel leaves.While fresh, the husk is green in color and 
the nut inside is very soft whereas in a ripe fruit the husk 
becomes yellow or orange and the fruit inside hardens to 
a wood like consistency (1). The seed or endosperm is 
consumed fresh, boiled, or after sun drying or curing.Are-
ca nut is chewed by itself or in the form of commercial 
preparations like supari, mawa, pan masala (2).Areca nut 
consumed with betel leaf, lime with or without tobacco is 
called as Paan or betel quid. It may include clove, carda-
mom, catechu, etc. for extra flavouring (1).
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and ulcers, and blanching of the mucosa for diagnosis 
of OSMF (10).
Due to this characteristic clinical appearance there are 
very few conditions that need to be differentiated from it 
such as scleroderma, anemia and lichen scerosus.
Scleroderma is an autoimmune condition affecting the 
connective tissue characterized by intense fibrosis of the 
skin with internal organ involement. Although there is 
restricted mouth opening, microstomia and xerostomia 
in these patients, presence of Raynaud’s phenomenon, 
widening of the periodontal ligament space and osseus-
resorbtion of the mandible, increased collagen fibers in 
the deep layers of the dermis and serological tests helps 
us to differentiate it from OSF (11). Usually pale muco-
sa seen in anemic conditions may be mistaken for OSF. 
Presence of habit, palpable fibrous bands, histological 
findings and hematological examination allow us to di-
fferentiate it from anemia (12). Lichen scerosus is a mu-
cocutaneous chronic inflammatory disease of uncertain 
origin mostly seen in females and predominently affects 
skin and genital mucosa. Oral involvement is rarely seen. 
Clinically it appears as an asymptomatic white macu-
le often on the gingiva and labial mucosa. Histological 
examination is important in differentiating it from OSF 
that shows hyalinization and connective tissue scerosis 
with absence of vascular lumen obliteration (13).
Although the pathogenesis of the disease is thought to be 
multifactorial, chewing of betel quid/areca nut has been 
recognized as one of the most significant risk factors for 
OSF (9).
The tremendous rise in the incidence of this condition 
has been reported. Worldwide estimates in 1996 indicate 
that 2.5 million people were found to be affected by this 
disease, whereas in 2002, in the Indian continent alone, 
the statistics for OSF was about 5 million people (0.5% 
of the population of India) (14,15).
In recent years marked increase in the occurrence of 
OSF was observed in many parts of India like Bihar, MP, 
Gujarat and Maharashtra and the younger generation are 
suffering more due to incoming of areca nut products in 
different multicolored attractive pouches (16).
The prevelance of OSF among patients attending dental 
OPD in Jaipur, Rajasthan, India in 2012 was found to be 
3.39% (17).
Therefore OSF is considered as a public health issue in 
many parts of world including the UK, South Africa, 
and many Southeast Asian countries (14,15). The reason 
for the continuous rise in the incidence of OSF could be 
attributed to increased popularity of commercially avai-
lable areca nut preparations, i.e., paan masala/gutkha 
in India and an increased uptake of this habit by young 
people due to easy access, effective price ranges, and 
marketing strategies.
The malignant transformation rate of OSF has been re-
ported to be around 7.6% over a 17-year period (7,18).
History
Indian culture and tradition hold areca nut and betel 
leaves in high esteem. Considered an auspicious in-
gredient in Hinduism, the areca nut is still used along 
with betel leaf in religious ceremonies and also while 
honouring individuals in most of Southern Asia. In the 
Indian subcontinent the chewing of betel leaf and areca 
nut dates back to the pre-Vedic period of Harappan Em-
pire.  Formerly in India and Sri Lanka it was a custom of 
the royalty to chew Areca nut and betel leaf. There was 
also a custom to chew Areca nut and betel leaf among 
lovers because of its breath-freshening and relaxant pro-
perties (3).
Effects of Areca Nut
Areca nuts are chewed with betel leaf for their effects as 
a mild central nervous system stimulant (4).The effect is 
thought due to one of its content known as arecoline that 
leads to alertness, increased stamina, a sense of well-be-
ing and euphoria. It is known to stimulate salivation and 
thus aiding in digestion. According to traditional Ayur-
vedic medicine, chewing areca nut is a good remedy for 
deworming and along with betel leaf it prevents halitosis 
(5).Along with these beneficial effects of areca nut one 
of its most harmful effects on the human body in gene-
ral and oral cavity in particular is the development of 
apotentially malignant disorder called Oral Submucous 
Fibrosis (OSF) (6,7).
Oral Submucous Fibrosis (OSF)
Oral submucous fibrosis (OSF) is a chronic, insidious 
oral mucosal condition that occurs predominantly 
among Indians and occasionally in other Asians especia-
lly Taiwanese and sporadically in Europeans. It was first 
described by Pindborg and Sirsat (8). It is regarded as a 
pre-cancerous condition (7).
The hallmark of the disease is submucosal fibrosis that 
affects the oral cavity and progressively involves the 
pharynx and the upper esophagus. It is characterized by 
juxta-epithelial inflammatory reaction followed by chro-
nic change in the fibro-elasticity of the lamina propria 
and is associated with epithelial atrophy. This leads to 
burning sensation in the oral cavity, blanching, and sti-
ffening of oral mucosa and oropharynx, resulting in res-
tricted mouth opening which in turn causes limited food 
consumption, difficulty in maintaining oral health, and 
impairs the ability to speak (6,9). 
The presence of palpable fibrous bands is a diagnostic 
criterion for OSF. The fibrous bands occur especially 
in the buccal mucosa,retromolar areas, and around the 
rimaoris. When the tongue is affected, it is devoid of 
papillae and becomes smooth. Its mobility, especially 
the protrusion, is impaired. The opening of the mouth 
is restricted. Some investigators adhered to the earlier 
signs and symptoms such as pain, history of vesicles 
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Histopathological Features of OSF
The initial pathology of OSF is characterized by juxta-
epithelial inflammation, including edema, large fibro-
blasts and an inflammatory infiltrate, consisting primarily 
of neutrophils and eosinophils (19).
Later, collagen bundles with early hyalinization are seen 
and the acute inflammatory infiltrate contains more chro-
nic cell types,such as lymphocytes and plasma cells, oc-
casionally resembling lichenoid mucositis. In more ad-
vanced stages, OSF is characterized by formation of thick 
bands of collagen and hyalinization extending into the 
submucosal tissues and decreased vascularity. The epithe-
lium lining frequently becomes thin and loses melanin or 
becomes hyperkeratotic. Occasionally dysplastic changes 
occur in the epithelium. Inflammation and fibrosis of mi-
nor salivary glands canalso be seen. Muscle degeneration 
occurs in advancedstages of OSF (19).
Role of Areca Nut in the Pathogenesis of OSF
A number of etiological factors have been discussed to play 
a role in the pathogenesis of this disease. Factors include 
areca nut chewing, ingestion of chillies, genetic and immu-
nologic processes, nutritional deficiencies. Various epide-
miological studies and histopathological effects on fibro-
blast and keratinocytes support the chewing of areca nut as 
one of the most important risk factors for OSF (14).
Areca nut is made up of alkaloid and flavonoid compo-
nents. Four alkaloids namely arecoline, arecaidine, guva-
cine, and guvacoline have been identified in areca nut, of 
which arecoline is the most potent agent and plays a major 
role in the pathogenesis of OSF by causing an abnormal 
increase in collagen production. The flavonoid compo-
nents like tannins and catechinshave been found to have 
some direct influence on collagen metabolism (14).
Basic mechanisms involved in the pathogenesis of OSF 
can be divided into four steps:
1. Occurrence of the chronic inflammation at the site of 
betel quid placement
2. Increased collagen synthesis
3. Collagen cross-linking
4. Decreased collagen degradation
- Occurrence of the chronic inflammation at the site of 
betel quid placement:
The areca nut chewing habit varies among individuals. 
The most common habit is placement of the betel quid in 
the vestibule for varying duration and frequency. Due to 
the constant contact between the betel quid and the oral 
mucosa, the alkaloids and the flavonoidsfrom the quid 
are absorbed and undergoes metabolism. These consti-
tuents along with their metabolites serve as a constant 
source of irritation to the oral mucosa. Along with this 
chemical irritation, the mechanical irritation of the oral 
mucosa also occurs due to the presence of the coarse 
fibers in the betel quid. The microtrauma resulting from 
this continues friction of coarse fibers of areca nut facili-
tates the diffusion of betel quid alkaloids and flavonoids 
into the subepithelial connective tissue, resulting in jux-
taepithelial inflammatory cell infiltration (14). Due to 
the persistent habit of areca nut chewing, chronic infla-
mmation sets in at the site. Inflammation is characterized 
by the presence of activated T cells, macrophages, etc. 
(Fig. 1). Synthesis of various inflammatory mediators 
like prostaglandins secreted by the oral keratinocytes in 
response to areca nut extract has been shown (20,21).
Cytokines like interleukin 6 (IL 6), tumor necrosis fac-
tor (TNF), interferon α and growth factors like Trans-
forming growth factor – beta (TGF-β) are synthesized 
at the site of inflammation (22). Initial irritation leads to 
Fig. 1. Schematic representation of chronic inflammatory process at the site of placement of the 
betel quid.
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the further atrophy and ulceration of the mucosa. Persis-
tent inflammation is essential for the occurrence of tis-
sue fibrosis and cancer (23). Hence the induction of oral 
mucosal inflammation by betel quid ingredients can be 
considered as a critical step in the pathogenesis of OSF.
-Increased collagen synthesis.
TGF- β is a key regulator of Extra- cellular matrix 
(ECM) assembly and remodelling. It helps in activation 
of procollagen genes and elevation of pro-collagen pro-
teinase levels (PCP – Procollagen C-proteinase, BMP 
1- bone morphogenetic protein1 PNP – Procollagen N-
proteinase).
Procollagen genes are transcribed and translated to form 
pro-collagen monomeric chains (procollagen precursor). 
Three of these monomers assemble into a trimer triple 
helix which is aided by disulphide bridge formation. 
These trimericprocollagen chains are acted upon by N 
and C – terminal proteases to cleave the terminal do-
mains and form the fibrils. The newly formed fibrils are 
then covalently stabilized through cross-linking to form 
a stable mature structure of collagen (14).
The genes COL1A2, COL3A1, COL6A1, COL6A3, and 
COL7A1 have been identified as definite TGF- β targets. 
The transcriptional activation of types I and type VII co-
llagen gene expression by TGF- β has been demonstra-
ted (23). Due to this it results in increased expression of 
procollagen genes and thus contributes to the increased 
collagen levels in OSF (Fig. 2).
Procollagen proteinases (PNP and PCP) helps in pro-
cessing of procollagen precursors into collagen fibrils, 
which are soluble. Thus TGF- β modulates both proces-
ses i.e. increased procollagen gene expression and pro-
cessing into fibrils by increased levels and activities of 
PCP and PNP (14).
The end result is increased collagen synthesis.
- Collagen cross-linkin:
The lysyl oxidase (LOX) is an essential enzyme for final 
processing of collagen fibers into a stabilized covalently 
cross-linked mature fibrillar form that is resistant to pro-
teolysis. The activity of LOX leads to the formation of 
insoluble collagen due to cross-linking. This gives ten-
sile strength and mechanical properties to the fibers and 
thus makes them resistant to proteolysis.
The LOX is a copper dependent enzyme (24). The con-
version of its precursor form i.e. pro-lysyl oxidase to 
its active LOX is mediated by BMP1 that occurs in ex-
tracellular matrix.(25). Copper is incorporated in LOX 
during its synthesis (26). Another important co-factor 
required for the reaction mechanism (cross linking of 
collagen fibers) of LOX is lysine tyrosylquinone (LTQ) 
(27). It is a covalently bound carbonyl prosthetic group. 
It is suggested that copper plays an important role in sta-
bilization of LTQ (28).
High levels of copper have been demonstrated in are-
ca nut. Chewing areca nut for 5 – 30 minutes increases 
the soluble copper levels in the oral fluids which in turn 
stimulates fibrogenesis through up-regulation of LOX 
activity (29,30).
Flavonoids present in the areca nut also play an impor-
tant role in the process of enhancing the cross-linking 
of the fibers. It has been demonstrated in in-vitro stu-
dies that presence of catechin raises the LOX activity 
(31,32).
TGF-β has been considered as an important factor in 
regulating the expression of LOX. The probable me-
chanism for this could be elevation of BMP1 by TGF-β 
which further mediates the bio-synthetic processing of 
LOX (25) (Fig. 3).
Fig. 2. Schematic representation of collagen synthesis regulated by TGF-β.
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Fig. 3. Schematic representation showing the mechanism involved in increased collagen cross-linking.
Thus increased LOX activity due to increased BMP and 
Copper levels and presence of flavonoids in areca nut 
leads to increased cross-linking of the collagen fibers, 
that are resistant to proteolysis.
- Decreased Degradation of collagen:
TGF-β decreases the collagen degradation by activation of 
tissue inhibitor of matrix metalloproteinase gene (TIMPs) 
and plasminogen activator inhibitor (PAI) gene.
Matrix metalloproteinases (MMPs) comprise of a set 
of structurally related degrading proteases. Their main 
function is tissue remodelling by degradation of ECM in 
health and disease. There are many types of MMPs but 
few MMPs like MMP 1, MMP8, MMP13 are referred 
as collagenases. The activities of MMPs are regulated at 
the level of transcription, activation of the pro-MMPs, 
and inhibition of endogenous inhibitors under normal 
physiological conditions (33).
TIMPs are specific inhibitors of MMPs and thus control 
their local activities in tissues. Studies have demonstra-
ted increased expression of TIMPs in OSF which are 
responsible for inhibition of collagenase and decrease in 
collagen degradation (34,35).
TGF-β activatesTIMP gene thus decreases the collagen 
degradation by inhibition of the activated collagenases. 
The flavonoids also have been shown to inhibit the co-
llagenase activity (14) (Fig. 4).
The plasminogen (Plg) activation system is an extra-
cellular proteolytic system that plays an important role 
in tissue remodelling (36). Plasmin is an active serine 
protease and is generated by proteolytic cleavage of Plg 
by tissue plasminogen activator (tPA). These activators 
are regulated by two plasminogen activator inhibitors, 
PAI1 and PAI2 (37).
Plasmin plays an important role in the activation of pro-
MMPs to active form, and thus facilitates the collagen 
degradation.  In OSF, it has been found that there is in-
crease in PAI1 which leads to inhibition of Plg activation 
process (37) (Fig. 4)
TGF-β has been shown to play a very important role in 
regulation of PAI1 with its stimulatory effect (38).
Thus there is inhibition of existing collagenase and de-
creased generation of active collagenase collectively re-
sulting in decrease in collagen degradation.
Apart from activation of TIMPs and PAI genes, another 
process which is responsible for decreased degradation 
of collagen is inhibition of collagen phagocytosis. Colla-
gen degradation by fibroblast phagocytosis has animpor-
tant role in physiologic collagen turnover. In vitro cul-
ture studies have demonstrated that there is reduction in 
the collagen phagocytic cells in OSF fibroblasts which 
was thought to be dose dependent with the amount of 
arecoline/arecaidine (39,40).
Conclusion
The alkaloid and flavonoid content of the areca nut plays 
a very important role in the major events that occur in 
pathogenesis of OSF. They enhance the collagen pro-
duction, strengthen the cross-linking and reduce their 
degradation by various discussed molecular pathways. It 
is a progressive process and hence relieving the patient’s 
symptoms to improve the life quality forms the basis of 
its management. Its potential to turn into malignancy is 
also of concern. It is well said that ‘Prevention is better 
than cure’ and it holds true in case of the management of 
this irreversible disease. Thus cessation of the areca nut 
chewing habit forms the mainstay for the therapy.
e574
J Clin Exp Dent. 2014;6(5):e569-75. Areca nut in oral submucous fibrosis
Fig. 4. Schematic representation showing mechanisms involved in decreased collagen degradation.
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